Sean Murphy, Chief Manuf, Strategy&Bus Development at TriSalus Life Sciences, Inc. (TLSI), bought 42,500 shares at $5.31 ($157K) on 2025-01-27, disclosed to the SEC on 2025-01-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 12,500 | $0 | 0.0% |
| 2 | $5.31 | 15,000 | $80K | 50.7% |
| 3 | $5.17 | 15,000 | $78K | 49.3% |
| Total | $3.70 avg | 42,500 | $157K | 100% |